Fujifilm‘s (TSE:4901) SonoSite subsidiary said earlier this week it appointed Fujifilm vet and current Fujifilm Medical Systems USA and Fujifilm New Development USA prez Takaaki Ueda as its new chair and CEO. Previously, Ueda has also served as Fujifilm global endoscopy systems division GM, the company said. Ueda will replace the departing Masayuki Higuchi who […]
7 medtech stories we missed this week: June 22, 2018
From Accuray’s India approval to Masimo and PositiveID launching a Bluetooth-enabled thermometer, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. India approves Accuray’s Radixact X9 radiation therapy device Accuray announced in a June 21 press release that it has received an Atomic Energy Regulatory Board Type Approval in […]
PositiveID deals FireFlyDX POC diag assets to subsidiary ExcitePCR, which looks to raise $3m
PositiveID (OTC:PSID) said last week it is dealing its stake in the FireFlyDX point-of-care diagnostic system to its subsidiary ExcitePCR as it looks to streamline future development of the system, contingent on a financing deal worth at least $3 million. PositiveID is selling the assets to the subsidiary through the acquisition of 10.5 million shares of […]
PositiveID acquires mobile lab developer E-N-G Mobile Systems
PositiveID (OTC:PSID) said today it acquired specialty vehicle and mobile lab developer E-N-G Mobile Systems for approximately $1 million. ENG’s fastest growing division was its mobile labs segment, which included chemical, biological, nuclear, radiological and explosives testing, PositiveID said. TheDelray Beach, Fla.-based company said it plans to add its bio-detection technology to the labs to offer […]
PositiveID picks up Thermomedics
PositiveID (OTC:PSID) said yesterday it acquired non-contact thermometer manufacturer Thermomedics for $750,000 up front and another possible $750,000 in 2016 and 2017 dependent upon reaching certain milestones. Thermomedics produces the Caregiver non-contact clinical-grade infrared thermometer, which is FDA cleared for measuring forehead temperature in adults, children and infants. No skin contact is required to use the […]
DOD hands out $99.6 million in contracts to Hologic, GE, PositiveID | Medtech funding stories for the week of Apr. 7, 2014
Hologic, GE, PositiveID land near $100M in Defense contracts
The U.S. Dept. of Defense handed out $99.6 million in contracts to a trio of device makers, providing for radiology systems, patient monitoring and airborne bio-threat detection for a variety of military and civilian agencies.
Covidien restates Q2 financials ahead of pharma spinout | Wall Street Beat
Covidien (NYSE:COV) re-stated its financial results for the fiscal 3rd quarter ended March 29, in anticipation of the planned spinout of its Mallinckrodt pharmaceuticals business next month.
Covidien said the new numbers reflect the pharma unit as a discontinued operation, with COV shareholders slated to receive a tax-free distribution, according to a regulatory filing.
PostiveID bails on iGlucose technology, licenses out for $2M
PositiveID (OTC:PSID) licensed its iGlucose technology for a cool $2 million to Smart Glucose Meter Corp. as part of its shift toward molecular diagnostics.
The deal, valued at up to $2 million, could be worth up to $5 per patient per year for Smart Glucose Meter, according to a regulatory filing.
Lost lawsuit pushes HemCon Medical into bankruptcy | Wall Street Beat
HemCon Medical Technologies said it’s filing for Chapter 11 bankruptcy protection for its U.S. operation after losing a $34.2 million court decision last month, saying it plans to appeal the ruling.
In March a sharply split U.S. Court of Appeals for the Federal Circuit reversed course and reinstated a win for Marine Polymer Technologies in its wound dressing patent spat with HemCon.
MassDevice Network
@MassDevice
LinkedIn